Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS

v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Oct. 02, 2022
Jan. 02, 2022
Current assets:    
Cash and cash equivalents $ 349,007 $ 385,293
Accounts receivable, net 6 0
Inventory 452 0
Deferred contract costs 1,539 4,554
Prepaid expenses and other current assets 4,507 8,274
Total current assets 355,511 398,121
Property and equipment, net 103,991 76,613
Operating lease, right-of-use assets 6,270 6,669
Other assets, non-current 1,787 1,162
Total assets 467,559 482,565
Current liabilities:    
Accounts payable 6,816 3,144
Accrued expenses 2,476 7,109
Accrued compensation 6,169 4,101
Deferred revenue 1,373 5,575
Other liabilities 695 707
Total current liabilities 17,529 20,636
Warrant liability 80,220 124,260
Operating lease liabilities, non-current 8,449 9,071
Deferred revenue, non-current 2,964 2,290
Other liabilities, non-current 114 191
Total liabilities 109,276 156,448
Commitments and Contingencies (Note 7)
Stockholders’ equity:    
Common stock, $0.0001 par value; authorized shares of 1,000,000,000; issued and outstanding shares of 157,077,599 and 152,272,287 as of October 2, 2022 and January 2, 2022, respectively 15 15
Preferred stock, $0.0001 par value; authorized shares of 10,000,000; no shares issued or outstanding as of October 2, 2022 and January 2, 2022, respectively 0 0
Additional paid-in-capital 731,861 659,254
Accumulated deficit (373,593) (333,152)
Total stockholders’ equity 358,283 326,117
Total liabilities and stockholders’ equity $ 467,559 $ 482,565